Scandinavian Medical Solutions A/S (CPH:SMSMED)
Denmark
· Delayed Price · Currency is DKK 3.810
+0.160 (4.38%)
At close: Dec 5, 2025
CPH:SMSMED Income Statement
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2020 |
| Revenue | 245.44 | 226.68 | 191.19 | 110.53 | 71.64 | Upgrade
|
| Revenue Growth (YoY) | 8.28% | 18.56% | 72.98% | 54.29% | 70.78% | Upgrade
|
| Cost of Revenue | 211.16 | 186.58 | 156.46 | 87.85 | 57.76 | Upgrade
|
| Gross Profit | 34.28 | 40.1 | 34.73 | 22.68 | 13.88 | Upgrade
|
| Selling, General & Admin | 23.76 | 19.09 | 13.65 | 7.33 | 2.98 | Upgrade
|
| Other Operating Expenses | 0.1 | - | - | - | - | Upgrade
|
| Operating Expenses | 32.49 | 26.35 | 18.1 | 7.94 | 3.01 | Upgrade
|
| Operating Income | 1.79 | 13.75 | 16.63 | 14.74 | 10.87 | Upgrade
|
| Interest Expense | -2.15 | -5.23 | -0.98 | -0.25 | -0.54 | Upgrade
|
| Interest & Investment Income | 0.58 | 1.55 | 0.14 | 0.22 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | 0.2 | Upgrade
|
| Pretax Income | 0.22 | 10.07 | 15.79 | 14.71 | 10.54 | Upgrade
|
| Income Tax Expense | 0.19 | 2.28 | 3.57 | 3.34 | 2.38 | Upgrade
|
| Net Income | 0.03 | 7.79 | 12.22 | 11.37 | 8.16 | Upgrade
|
| Net Income to Common | 0.03 | 7.79 | 12.22 | 11.37 | 8.16 | Upgrade
|
| Net Income Growth | -99.67% | -36.30% | 7.49% | 39.42% | 80.82% | Upgrade
|
| Shares Outstanding (Basic) | 28 | 27 | 27 | 27 | - | Upgrade
|
| Shares Outstanding (Diluted) | 28 | 27 | 27 | 27 | - | Upgrade
|
| Shares Change (YoY) | 0.67% | 0.57% | 2.22% | - | - | Upgrade
|
| EPS (Basic) | 0.00 | 0.28 | 0.45 | 0.43 | - | Upgrade
|
| EPS (Diluted) | 0.00 | 0.28 | 0.45 | 0.43 | - | Upgrade
|
| EPS Growth | -99.67% | -36.66% | 5.15% | - | - | Upgrade
|
| Free Cash Flow | -34.22 | -15.08 | -49.19 | -24.33 | 4.02 | Upgrade
|
| Free Cash Flow Per Share | -1.24 | -0.55 | -1.80 | -0.91 | - | Upgrade
|
| Gross Margin | 13.97% | 17.69% | 18.16% | 20.52% | 19.38% | Upgrade
|
| Operating Margin | 0.73% | 6.07% | 8.70% | 13.34% | 15.18% | Upgrade
|
| Profit Margin | 0.01% | 3.44% | 6.39% | 10.29% | 11.39% | Upgrade
|
| Free Cash Flow Margin | -13.94% | -6.65% | -25.73% | -22.01% | 5.62% | Upgrade
|
| EBITDA | 10.41 | 21.01 | 21.08 | 15.35 | 10.9 | Upgrade
|
| EBITDA Margin | 4.24% | 9.27% | 11.03% | 13.89% | 15.21% | Upgrade
|
| D&A For EBITDA | 8.62 | 7.26 | 4.46 | 0.61 | 0.02 | Upgrade
|
| EBIT | 1.79 | 13.75 | 16.63 | 14.74 | 10.87 | Upgrade
|
| EBIT Margin | 0.73% | 6.07% | 8.70% | 13.34% | 15.18% | Upgrade
|
| Effective Tax Rate | 87.91% | 22.66% | 22.60% | 22.70% | 22.61% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.